학술논문
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy
Document Type
Article
Author
Source
In: International Journal of Cancer . (International Journal of Cancer, 15 June 2024, 154(12):2142-2150)
Subject
Language
English
ISSN
10970215
00207136
00207136